<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>在III期试验中，Proxalutamide降低了Covid患者的死亡率 In a Phase III trial, Proxalutamide reduced mortality of Covid patients</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script>
<script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">In a Phase III trial, Proxalutamide reduced mortality of Covid patients<br/>在III期试验中，Proxalutamide降低了Covid患者的死亡率 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2021-03-20 09:08:28</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2021/3/05f1daabed3d308d93f60f635c6b35a8.jpg"><img src="http://img2.diglog.com/img/2021/3/05f1daabed3d308d93f60f635c6b35a8.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>In a Phase III trial, Proxalutamide reduced mortality and expedited recovery of hospitalised COVID-19 patients in Brazil.</p><p>在III期试验中，预达甲酰胺降低了死亡率，并加速了巴西住院的Covid-19患者的复苏。</p><p>  In a clinical trial, Proxalutamide reduced COVID-19 mortality risk by 92 percent and shortened the median hospital stay of patients by nine days.</p><p>  在临床试验中，Proxalutamide将Covid-19死亡率降低了92％，并缩短了九天患者的中位医院入住。</p><p> The investigator-initiated trial ( NCT04728802), conducted by Dr Andy Goren and Dr Flávio Adsuara Cadegiani at 12 sites in the Brazil, is a placebo-controlled, double-blinded randomised parallel assignment study. The trial has two cohorts (men and women) and two arms (Proxalutamide and control). It enrolled 588 patients, aged 18 years and older with a clinical status of 3, 4 or 5 on the WHO COVID-19 Ordinal Scale (3 = hospitalised patients not needing oxygen therapies, 4 = hospitalised patients needing oxygen by mask or nasal prongs and 5 = severely ill hospitalised patient on non-invasive ventilation or high-flow oxygen).</p><p> 由Andy Goren和Brazil的12个地点进行的Andy Goren和FlávioAdsuaraCadegiani博士进行的调查员启动的试验（NCT04728802）是安慰剂控制的双盲随机分配研究。该试验有两个队列（男女）和两臂（替纳氟胺和对照）。它注册了588名患者，年龄18岁及以上，临床地位为3,4或5人，在Covid-19序数（3 =住院患者不需要氧疗法，4 =由面膜或鼻叉的住院患者使用氧气5 =在非侵入式通风或高流量氧气上严重生病的住院患者。</p><p> In the Proxalutamide arm, patients were orally administered 300mg of the drug once daily for 14 days. In the control arm, patients were orally administered placebo once daily for 14 days. Each arm also received standard of care as determined by the principal investigator at the site.</p><p> 在Proxalutamide臂中，患者每天一次口服300mg药物14天。在控制臂中，患者每天一次口服安慰剂14天。每个臂也接受了本地主要调查员确定的护理标准。</p><p>  The trial met its primary endpoint, with Proxalutamide significantly reducing patient statuses on the Ordinal Scale at day 14. Proxalutamide achieved a reduction of 4.01 from baseline (5.663 to 1.653), compared to control with a reduction of 0.25 from baseline (5.618 to 5.368).</p><p>  该试验达到其主要终点，具有近甲酰胺在第14天的序列尺度上显着降低患者状态。比较与基线减少0.25的基线（5.663至1.653）达到4.01的减少4.01（5.618至5.368） 。</p><p> Proxalutamide was also found to reduce the mortality risk by 92 percent; overall, 11 patients died by day 14 in the treatment arm, making the mortality rate 3.7 percent, comparatively there were 141 deaths in the control arm, a 47.6 percent mortality rate.</p><p> 还发现毕甲酰胺，将死亡率降低92％;总体而言，11名患者在治疗臂中的第14天死亡，使死亡率为3.7％，对照组中有141人死亡，死亡率为47.6％。</p><p> Additionally, treatment with the nonsteroidal antiandrogen shortened median length of hospital stay by nine days (five days with Proxalutamide versus 14 with control) and after 14 days, 89.1 percent of those treated with Proxalutamide were discharged, more than double the 32.8 percent in the control arm.</p><p> 另外，用非甾体抗原性腺素的治疗缩短了医院的中位数，保持了九天（五天与对照，14天后，14天后，用Proxalutamides处理的89.1％的物质排出，对照中的32.8％增加了32.8％手臂。 </p><p> Dr Tong Youzhi, Founder, Chairman and Chief Executive Officer of Kintor Pharmaceutical Limited (the developer of the drug), commented: “This trial for treatment of hospitalised COVID-19 patients was conducted in 12 sites in the Brazilian state of Amazonas, where the pandemic has been devastating. Most of the newly test-positive patients in Amazonas have been infected by the new P.1 variant, which is more contagious and has led to a higher mortality rate. We are delighted to see that Proxalutamide could significantly reduce the mortality rate, shorten the length of hospital stay, reduce the number of new mechanical ventilations (MV) and increase the percentage of discharge from hospital, thus alleviating shortages of public health resources in Amazonas.</p><p>Kintor Pharmaceutical Limited（药物开发商）桐友智博士，创始人，主席和司人的开发商）评论：“这种用于治疗住院的Covid-19患者的试验在巴西亚马逊巴西州的12个地点进行了大流行一直在毁灭性。亚马索斯的大多数新测试阳性患者被新的P.1变体感染，这更具传染性，并导致了更高的死亡率。我们很高兴看到毕斋胺可以显着降低死亡率，缩短住院时间，减少新机械通风（MV）的数量，增加医院的排放百分比，从而减轻了亚马逊公共卫生资源短缺。</p><p> “Based on the positive results of this Phase III trial, the treatment of COVID-19 outpatients, hospitalised patients (including those admitted to Intensive Care Units), we expect Proxalutamide could become an important tool in the global fight against COVID-19.”</p><p> “基于该第三阶段试验的阳性结果，治疗Covid-19门诊患者，住院患者（包括入院的人，录取重症监护单位），我们预计Proxalutamide可能成为全球对抗Covid-19的重要工具。”</p><p> Proxalutamide (GT-0918) is a nonsteroidal antiandrogen which was developed for the treatment of prostate and breast cancer.</p><p> Proxalutamide（GT-0918）是一种非甾体抗抗抗原，用于治疗前列腺和乳腺癌。 </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.europeanpharmaceuticalreview.com/news/147167/proxalutamide-reduces-covid-19-mortality-risk-by-92-percent/">https://www.europeanpharmaceuticalreview.com/news/147167/proxalutamide-reduces-covid-19-mortality-risk-by-92-percent/</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/降低/">#降低</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/iii/">#iii</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/患者/">#患者</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy;2012-2021 diglog.com </div></div></body></html>